Sequentify
Rehovot
About Sequentify
Sequentify provides a technology that is based on tools from the synthetic biology and AI software worlds for targeted DNA sequencing applications such as cancer diagnostics, carrier screening, COVID-19 surveillance and other applications.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $8.3M
- Funding stage: Seed
- Last round: Grant (Jan 2024)
- Website: sequentify.com
- Phone: [email protected]
Industries & Categories
Health Care, Health Diagnostics, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/sequentify-48665 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.